General MedicationsORALStandard
NEXICLON XR
CLONIDINE
Standard Dose
EQ 0.17MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview NEXICLON XR is listed in Drugs@FDA under application 022500 (NDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient CLONIDINE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 0.17MG BASE Sponsor ROSEMONT Submission history Latest submission status date: 2010-09-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEXICLON XR is listed in Drugs@FDA under application 022500 (NDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient CLONIDINE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 0.17MG BASE Sponsor ROSEMONT Submission history Latest submission status date: 2010-09-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.